To develop a less reactogenic but equally immunogenic vaccine, this study of 91 human volunteers compared the safety and immunogenic potency of a new, cell culture -derived vaccinia virus vaccine administered intradermally and intramuscularly with the licensed vaccinia vaccine administered by scarification. Cutaneous pox lesions developed in a higher proportion of scarification vaccinees. Scarification and intradermal vaccine recipients who developed cutaneous pox lesions had more local reactions but also achieved significantly higher cell-mediated and neutralizing antibody responses than those who did not develop pox lesions. Although less reactogenic, intradermal or intramuscular administration of vaccinia vaccine without the concomitant development of a cutaneous pox lesion induced lower immune responses.
Vaccinia virus is a member of the Orthopox genus of the Practices. Certain US military units may require smallpox vacpoxvirus family and has little virulence for immunocompetent cination during future deployments. Apart from military needs, humans. Apart from its critical role in the eradication of enthe Centers for Disease Control and Prevention (CDC) has demic smallpox, vaccinia virus has several biologic properties recommended vaccination for persons working in the laborathat make it an excellent candidate for introducing foreign tory with vaccinia or recombinant vaccinia viruses [7] . Theregenes that prompted the investigation of recombinant vaccinia fore, it is important that modern production techniques be apvaccines [1 -3] . However, cellular immunity and antibody replied to the manufacture of a vaccinia virus vaccine to make sponses to vaccinia virus administered by different routes have it safe and effective as a replacement for the current calf lymph not been compared in humans. These issues bear importance smallpox vaccine. Given the attendant risks associated with the on how such vaccines will be used in humans and perhaps traditional method of cutaneous inoculation of vaccinia, we why immune responses to recombinant vaccinia vaccines have sought to evaluate the clinical and immune responses of alternarequired multiple injections [4 -6] .
tive routes of inoculation by using a new, cell culture -derived The only vaccinia vaccine currently licensed in the United vaccinia vaccine. States was prepared from calf lymph and is stored as a freeze-
The vaccinia vaccines used in the smallpox eradication effort dried product. Supplies of this licensed vaccine cannot be rewere prepared on a large scale by inoculating the shaved abdoplaced, as the production method for calf lymph vaccine is mens of calves, sheep, or water buffalo with seed stocks of archaic and there is no adequate facility in which supplies vaccinia virus, harvesting the infected exudative lymph from can be regenerated in compliance with Good Manufacturing the inoculation sites, and bottling the product with phenol and brilliant green as bacteriostatic agents [8, 9] . Partly because of the nature of this production, in which bacterial contamination was expected, the vaccines were administered percutaneously with a bifurcated needle, a process that became known as scari- and for potential systemic symptoms related to vaccination. Any eth-Ayerst Laboratories, Philadelphia) is a lyophilized vaccinia local reaction at the inoculation site was measured to determine virus derived from the New York Board of Health strain [7] and the diameter of any local erythema and induration and scored for is the only remaining licensed vaccinia vaccine in the United the presence or absence of warmth, tenderness, lymphadenopathy, States. The cell-cultured vaccinia vaccine was manufactured acsubcutaneous nodule, or a vesicle (pox) lesion. Systemic reactions cording to Good Manufacturing Practices after three successive were assessed by questioning and examining the volunteers for the passages in MRC-5 cells. This vaccine lot was derived from the presence and severity of fever, chills, malaise, headache, myalgia, master seed of the smallpox vaccine previously licensed by Conarthralgia, loss of appetite, nausea, vomiting, diarrhea, pruritus, naught Laboratories (Philadelphia). The Connaught vaccine was or rash. These symptoms were quantitatively scored based upon one of several licensed vaccinia products used in the United States severity (0 Å no symptom; 1 Å mild, symptom can be ignored; until the end of smallpox vaccination in the early 1970s.
2 Å moderate, symptom affects activity but is relieved by analgeThe cell culture-derived vaccinia vaccine was administered in sics; and 3 Å severe, symptom cannot be relieved by analgesics). a dose of 5.1 log 10 pfu, either as 0.1 mL id or 0.5 mL intramuscuData were entered into a database for subsequent statistical analylarly (im). The licensed vaccinia vaccine was administered by sis. The total local or systemic symptom score for a given vaccinee scarification (as directed in the package insert) by dipping a sterile was defined as the sum of all scores for either local or systemic bifurcated needle into the vaccine and then pricking the skin inocusymptoms. lation site three times. The licensed vaccinia vaccine has a virus Clinical laboratories. Blood samples were obtained by weekly titer of Ç10 8 pfu/mL, and the administration of 1 drop via scarifiphlebotomy of volunteers, beginning before vaccination until Ç1 cation with a bifurcated needle is estimated to deliver 2.5 mL.
month after vaccination. A complete blood cell count with a fiveTherefore, Ç10 5 pfu is delivered by this method. All vaccinations part differential cell count was done using a cell counter (CellDyn were administered into the deltoid region of the arm. 3000; Abbott Laboratories, Abbott Park, IL). Serum samples were Subjects. The vaccines were administered in an open-label analyzed by an Ektachem 700XR (Eastman Kodak, Rochester, NY) for a panel of chemistry measurements (sodium, potassium, study to healthy vaccinia-naive volunteers. Volunteers were chloride, bicarbonate, urea nitrogen, creatinine, glucose, calcium, 2% heat-inactivated FBS. Cultures were incubated at 35ЊC in a humidified atmosphere of 5% CO 2 for 4-6 days. Cultures were phosphorus, lactate dehydrogenase, aspartate transaminase, alanine transaminase, g glutamyl transferase, alkaline phosphatase, total decanted and fixed with 1 mL (200 mL for the 96-well plates) of 10% formalin for 15 min at room temperature. Plates were incubilirubin, and creatine phosphokinase). Test value means were calculated for each group on a given day of measurement. The bated with 1 mL (200 mL for the 96-well plates) of HBSS containing 1% bovine serum albumin (BSA) for 30 min. The blocker data from each hematologic and serum chemistry test were analyzed using Statistical Analysis System procedure GLM (version buffer was removed and 0.5 mL (50 mL for the 96-well plates) of a 1:1000 dilution of vaccinia mouse hyperimmune ascitic fluid 6.10; SAS, Cary, NC) repeated measures analysis of variance (ANOVA). The overall differences between groups over the course (ATCC, Rockville, MD) or normal mouse ascitic fluid was added to the appropriate wells for 1 h at 35ЊC. After three washes, 0.2 of the study period were compared by using the univariate tests of hypothesis for within-subjects effects. and negative controls were tested in duplicate. A positive control was prepared using 10-fold dilutions of vaccinia virus in negative (Kirkegaard & Perry, Gaithersburg, MD). Given a lower limit of detection of the assay at a 1:100 test serum dilution, negative titers antibody serum. Using these ''spiked'' serum samples, 2 wells were inoculated with each dilution. Two wells were also inocu-(i.e., optical density comparable to background) were reported as equal to 1:50. lated with normal (noninfectious) human serum as a negative control. Results were read visually or spectrophotometrically at PRNT, an in vitro test of serum's ability to neutralize the Wyeth strain of vaccinia virus, was determined using a modification of 414 nm. Titers were calculated as TCID 50 values according to the method of Reed and Muench [16] or as the highest specimen the method of Earley et al. [13] . Briefly, each coded serum sample was incubated at 56ЊC for 30 min, then diluted 1:10 in Eagle MEM dilution with an optical density of 0.
units over that of the negative controls. (EMEM) containing 10% heat-inactivated fetal bovine serum (FBS). A suspension of vaccinia virus, calculated to yield a dose
Statistical methods. The PRNT and ELISA antibody responses were analyzed by variance with repeated measures followed by of Ç40-100 pfu/0.1 mL, was prepared in Hanks' balanced salt solution (HBSS) with 40 mM HEPES. Two-fold dilutions of serum multiple comparisons for the study groups using the Tukey-Kramer adjustment for multiplicity [17] . The data from each hematologic samples were then mixed 1:1 with 40-100 pfu of vaccinia virus suspension and incubated at 37ЊC for 1 h. After incubation, test and serum chemistry test and lymphocyte transformation assays were analyzed for each study group by using SAS procedure GLM samples and controls were inoculated onto monolayers of Vero cells in 12-well cell culture plates. After adsorption for 1 h at ANOVA. The overall differences between groups over the course of the study were compared by using the univariate tests of hypoth-37ЊC, each monolayer was overlaid with 1 mL of 0.5% agarose (FMC Bioproducts, Rockland, ME) containing HEPES-buffered esis for within-subjects effects. All statistical tests were performed at the a Å .05 level unless otherwise indicated. Eagle basal medium with Earle's salts, and 5% heat-inactivated FBS. After incubation for 2 days at 37ЊC in a humidified atmosphere of 5% (vol/vol) carbon dioxide (CO 2 ), each monolayer was stained with 1 mL of the agarose overlay containing 0.167 mg/ week yielded no significant differences between the study inoculated with 0.1 mL or 50 mL, respectively, of a serum sample.
Results
groups' temperature profiles (temperature maximums recorded
After adsorption for 1 h at 35ЊC, the 24-well plates were re-fed with 1 mL (100 mL for the 96-well plates) of EMEM containing each week).
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The vaccinees inoculated id who received alcohol wiping areas of contact dermatitis from dressing adhesive were observed. after inoculation and the vaccinees inoculated im did not significantly differ with respect to incidence of pox lesion (25% Clinical laboratories. Laboratory findings were based on the analysis of the weekly mean for each subject for weeks vs. 4.5%, P Å .141). However, failure to wipe with alcohol increased the incidence in the group inoculated id to 62.5%, 01, 0, 1, 2, 3, and 4. Due to some missing values when volunteers omitted scheduled phlebotomies, no repeated measures which was significantly higher then that in the group inoculated im (P õ .001). This was significantly less than the incidence ANOVA could be done. Hence, an ANOVA was done at each week. Only sporadic differences were detected for any postof pox lesions in the scarification group (96.6%), which was higher than that in all the other groups (P õ .001).
treatment week (noted in table 1.) Serologic and virologic assays. PRNTs were significantly The scarification group had the highest incidence of local reactions, the group inoculated im experienced the fewest, and greater for the scarification group than for the groups inoculated either im or id beginning at day 13 after inoculation (P õ .001) the subgroups inoculated id were intermediate and indistinguishable from each other. Local symptom analysis indicated using a repeated measures ANOVA. Moreover, volunteers from either scarification or groups inoculated id who developed highly significant statistical differences between the study groups, using both ANOVA and nonparametric Wilcoxon analcutaneous pox lesions had significantly higher neutralization titers than those without pox lesions in comparisons adjusted yses (P õ .001). There was a higher total symptom score for the scarification group (mean, 169.2) and a significantly lower for prevaccination baseline. There was no significant difference between volunteers inoculated by scarification or id who had score for the group inoculated im (mean, 3.0). Mean total scores for vaccinees inoculated id with and without alcohol wiping developed a cutaneous vesicle. However, there was a statistically insignificant trend toward higher titers in the scarification were 61.7 and 90.4, respectively. Additional analysis exclusive of the group inoculated im revealed that the scarification group (Wyeth vaccine) recipients. These PRNT responses are illustrated in figure 1. still differed from the subgroups inoculated id (P õ .001 by ANOVA or nonparametric analysis). When the two subgroups As illustrated in figure 2 , vaccinia ELISA antibody responses were significantly higher for the scarification group at day 27 inoculated id were compared, no differences were found in local symptom scores (P Å .215 by ANOVA, P Å .406 by after vaccination than for either of the groups inoculated id or im (P õ .001). In contrast to PRNT responses, significantly nonparametric analysis). When local symptom scores were compared between volunteers who did and did not develop higher ELISA titers were found in scarification vaccinees than in those inoculated id who formed a cutaneous pox lesion (P cutaneous pox lesions, overall and weekly score differences were significant (P Å .0001, nonparametric Wilcoxon test).
õ .001). There was greater standard error in this assay than in the PRNT assay. No viremia was detected in any volunteer. Systemic symptom analysis indicated no significant differences in the study groups with respect to total symptom scores Lymphocyte proliferation assays. Lymphocyte proliferation assays examined stimulation indices before and after vaccieither by ANOVA (P Å .352) or by nonparametric Wilcoxon test (P Å .412). However, higher mean systemic scores ocnation to both live vaccinia virus and heat-inactivated antigen. For the heat-inactivated antigen, responses to scarification were curred 2 weeks after inoculation in volunteers who developed a cutaneous pox lesion (P Å .038).
All volunteers initially had their immunization sites covered with a vapor-permeable surgical dressing until pox lesions [18] . All were attenuated when compared with standard lymph strains, and some were possibly overattenuated, producing low neutralizing antibody levels after primary and booster inoculations [19] . With the eradication of smallpox following closely upon initial development of most of these vaccines, comparable safety and efficacy data were not obtained on a scale comparable to that for lymph vaccines. In addition, data about cell-mediated responses were not documented for these injectable products.
In this study, vaccination reactions were readily apparent from clinical observation alone. Extensive laboratory monitoring of vaccinees identified no specific safety concerns or issues about the routes of vaccine administration. There was no evidence of viremia in any volunteer. Serum chemistry or hematology value differences between study groups were sporadic and relatively small. Given the number of data points and comparisons in this study, these were likely to be type I errors. As these statistical differences do not represent medically im-50% responses as illustrated by geometric mean titers (GMTs). PRNTs were significantly higher for scarification inoculees on reportant differences in a contiguous time frame, we do not attripeated measures analysis of variance (P õ .001) but not significantly bute them to causal events related to respective treatments.
higher than intradermal (id) injection recipients who developed a
The study indicated that, although not severe, local reactions cutaneous pox lesion (id w/ pox) after vaccination (P Å .09). id corresponded to formation of a cutaneous pox lesion. As exw/o pox Å intradermal injection recipients without pox lesion after pected, pox lesion incidence was significantly higher in the vaccination; im Å intramuscular injection recipients.
scarification group than in the other groups, as were local symptoms. In addition, higher systemic scores occurred 2 weeks after inoculation in volunteers who developed a cutaneous pox significantly greater than those of either subgroup inoculated im or id with alcohol wiping after inoculation (P Å .0258) but not significantly different from those in the group inoculated id without alcohol wiping (P Å 0.46). With live vaccinia virus as the antigen, scarification vaccinees had significantly higher stimulation indices (P Å .0037) than did either group inoculated im or id. Both higher indices and greater standard deviation were seen in the assay with heat-inactivated antigen in comparison to the live virus assay.
For volunteers who developed a pox lesion (whether id or by scarification), the stimulation indices before and after vaccination were significantly greater than for vaccinees who did not develop a cutaneous pox lesion, whether assayed using live virus or heat-inactivated antigen (P õ .001). There was no significant difference in lymphocyte stimulation responses between those who formed pox lesions from the licensed vaccinia vaccine via scarification and those with pox lesions from the cell-cultured vaccinia vaccine. These mean lymphocyte responses for heat-inactivated antigen are illustrated in figure 3 . The study also demonstrated that inoculation id will not reliably prevent the formation of a cutaneous pox lesion. Phase I data had raised similar concerns regarding the subcutaneous route of inoculation. In a study by Connor et al. [21] , typical Jennerian vesicles were seen in 4% -9% of children vaccinated subcutaneously with 10 3 , 10 4 , or 10 5 pfu. Furthermore, it is apparent that the presence of such a lesion, although undesirable for safety reasons, is necessary for the most robust immune responses. By cleansing the inoculation site after inoculation, we sought to determine if immune recognition afforded by intradermal processing of antigen could be achieved without the safety risks attendant to a cutaneous pox lesion. This concept stemmed from a previous observation that the cutaneous vesicle was prevented after inoculation id with vaccinia if the needle wound was immediately cleansed with alcohol [22] . nificantly higher ELISA and neutralizing antibody responses. The poor responses to inoculation id (in those without pox lesions) and im confirm and expand on earlier observations lesion. Either vaccine dissimilarities or the route of vaccination could account for the symptomatic differences between scariconcerning injectable vaccinations in children [19] . The investigators of that study concluded that ''... until more is known fication vaccinees and vaccinees inoculated id who developed a pox lesion: Impurities and animal proteins peculiar to calf about the importance of neutralizing antibody in the immunity to smallpox, it would seem unwise to administer vaccine by lymph exudate could explain in part the reactivity of the licensed vaccinia vaccine, or scarification could permit greater the sub-cutaneous route...'' [21] . This conclusion was based on the relatively poor rates of seroconversion (67%), as meaviral replication than would intradermal inoculation. Given comparable results in preclinical tests and the fact that both sured by vaccinia-neutralizing antibodies, in children vaccinated subcutaneously compared with their percutaneously vacvaccines studied derived from New York Board of Health strains, it is unlikely that the cell culture -derived vaccinia virus cinated counterparts (87%), and the unimpressive neutralizing antibody responses upon successful percutaneous revaccination has enough sequence variation or intrinsic biologic disparities from the calf lymph -derived Wyeth vaccine to account for of children whose primary vaccination was subcutaneous. In addition to antibody responses, cell-mediated responses such differences. The vaccinees inoculated id who received alcohol wiping after inoculation and those inoculated im did were also superior in volunteers who developed pox lesions (whether inoculated id or by scarification). There was no signot significantly differ with respect to incidence of pox lesions, but the latter group had significantly fewer local symptoms nificant difference in lymphocyte stimulation responses between those who formed pox lesions from the licensed vaccinia than did those inoculated id, who in turn had fewer than the scarification vaccinees.
vaccine by scarification and those with pox lesions from the cell culture -derived vaccinia vaccine. Inferior cell-mediated This study strongly indicated that, although less reactogenic, vaccinia vaccine administered im at a dose of 10 5 pfu fails to responses of vaccination without a pox lesion, as observed in this study, may explain why Connor et al. [21] reported that induce an immune response comparable to that elicited by standard scarification. Although a higher dose of vaccinia virus children who had initially received an injectable (subcutaneous) vaccine exhibited ú30% incidence of ''primary-type'' remight have been attempted im, the WHO Smallpox Eradication Campaign [10] and other clinical trials [18 -21] had supported sponses to percutaneous revaccination. This study also confirms the observation by Cherry et al. [20] of a correlation between the safety of a parenteral dose of 10 5 pfu, as used in this trial. In a phase I dose-escalation human trial, the cell cultureneutralizing antibody and lymphocyte stimulation responsiveness to vaccinia after vaccination. derived vaccinia vaccine was used safely subcutaneously up / 9d21$$ap43 02-11-97 18:22:00 jinfa UC: J Infect
An unexpected event in this phase II study was the high rus vectors that are incapable of productive replication in human-derived cell lines [25, 26] . incidence of secondary pox lesions adjacent to the inoculation site in the first set of volunteers (4/31). The use of semipermeWhen administration id of the cell-cultured vaccinia resulted in a cutaneous pox lesion, immune responses were not signifiable dressings appeared to have caused this complication, as no further instances occurred after instituting the use of dry cantly different from those seen with scarification with the licensed vaccinia vaccine. Although there is a statistically insiggauze dressings. Although vapor-permeable, the semipermeable dressings caused accumulation of perspiration around the nificant trend towards higher neutralization titers with the latter, future studies will examine the cell-cultured vaccine's immunoinoculation site despite frequent dressing changes, permitting virus-containing exudate to secondarily inoculate areas proxigenicity by this same scarification route. mate to the primary pox lesion. The large adhesive area of this dressing caused various degrees of contact dermatitis in several
